Keyphrases
Acute Coronary Syndrome
87%
Adverse Cardiac Events
64%
Meta-analysis
62%
COVID-19
59%
Systematic Meta-analysis
56%
Indonesia
49%
ST-elevation Myocardial Infarction (STEMI)
39%
Acute Myocardial Infarction
36%
Retrospective Cohort Study
35%
COVID-19 Pandemic
33%
COVID-19 Patients
33%
General Hospital
32%
Intensive Cardiac Care Unit
30%
Myocardial Infarction Patients
30%
Hypertension
28%
Poor Prognosis
23%
Coronary Artery Disease
23%
CMV Seropositivity
21%
Complex Coronary Lesions
21%
Age Groups
21%
Platelet-to-lymphocyte Ratio
21%
HIV Patients
21%
Randomized Placebo-controlled Trial
21%
Delta Variant
21%
Atorvastatin
21%
Subclinical Atherosclerosis
21%
COVID-19 Infection
21%
Cardiac Function
21%
Risk Factors
20%
Cardiovascular Disease
20%
Type 1 Diabetes Mellitus (T1DM)
18%
Pada
18%
Diagnostic Accuracy
17%
Multivariate Analysis
17%
Hospitalization
17%
Carotid Intima-media Thickness (cIMT)
16%
Immune Activation
16%
Tricuspid Annular Plane Systolic Excursion (TAPSE)
16%
Jakarta
15%
Hyperglycemia
15%
High Mortality
14%
Quality of Life
14%
High-sensitivity C-reactive Protein (hs-CRP)
13%
Sensitivity Specificity
13%
Acute Hyperglycemia
13%
Significant Relationship
13%
Cardiac Systolic Function
13%
Primary Percutaneous Coronary Intervention
13%
Indonesian
12%
Obesity
12%
Medicine and Dentistry
COVID-19
100%
Acute Coronary Syndrome
76%
Major Adverse Cardiac Event
63%
Meta-Analysis
43%
Infection
34%
Retrospective Cohort Study
33%
Lymphocyte
33%
Diagnostic Accuracy
32%
ST Segment Elevation Myocardial Infarction
32%
Coronary Care Unit
32%
Diabetes Mellitus
26%
Systematic Review
23%
Platelet
22%
Acute Heart Infarction
21%
Atorvastatin
21%
Atherosclerosis
21%
Human Immunodeficiency Virus
21%
Placebo
21%
Heart Function
21%
Cardiovascular Disease
21%
Cross Sectional Study
21%
Multivariate Analysis
18%
Prevalence
17%
Biological Marker
17%
Dyslipidemia
16%
Systolic Function
16%
Odds Ratio
16%
Quality of Life
15%
Cardiovascular Risk
14%
Ejection Fraction
14%
Diabetes
13%
Diastolic Function
13%
Percutaneous Coronary Intervention
13%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Primary Percutaneous Coronary Intervention
13%
Electrocardiogram
12%
Bivariate Analysis
12%
Maturity Onset Diabetes of the Young
12%
Medical Record
11%
Logistic Regression Analysis
11%
Echocardiography
10%
Hepatocellular Carcinoma
10%
Iron Overload
10%
Thalassemia Major
10%
Hemodialysis
10%
Zinc Deficiency
10%
Intima-Media Thickness
10%
Glomerulus Filtration
10%
QT Dispersion
10%
Blood Pressure Variability
10%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
65%
Major Adverse Cardiac Event
64%
Cohort Study
46%
Diseases
41%
Cardiovascular Disease
29%
Hyperglycemia
27%
Coronavirinae
26%
Acute Heart Infarction
25%
Heart Arrhythmia
25%
Infection
25%
Atherosclerosis
24%
ST Segment Elevation Myocardial Infarction
21%
Atorvastatin
21%
Placebo
21%
HIV
21%
Diabetes Mellitus
19%
Dyslipidemia
16%
Midazolam
16%
Congestive Heart Failure
16%
Coronary Artery Disease
14%
Cross-Sectional Study
14%
Pandemic
13%
C Reactive Protein
13%
Tumor Necrosis Factor
13%
SARS Coronavirus
13%
Cytokine
13%
Mortality Rate
11%
Heart Infarction
11%
Heart Ventricle Arrhythmia
10%
Thalassemia Major
10%
Thrombocytopenia
10%
Liver Cell Carcinoma
10%
Ferritin
10%
Hyperuricemia
10%
Iron Poisoning
10%
Hemodialysis
10%
Chlorogenic Acid
10%
Adult Respiratory Distress Syndrome
10%
Heart Muscle Injury
10%
CD8 Antigen
10%
Beta Thalassemia
10%
Alpha Fetoprotein
10%
Anticoagulant Agent
10%
Clinical Trial
10%
Frailty
10%
Anterior Myocardial Infarction
10%
Chronic Obstructive Lung Disease
10%
Messenger RNA
10%
Fenofibrate
10%
Connective Tissue Disease
10%
